Skip to content

The effect of orexin in hypertensive disorder of pregnancy (HDP)

The effect of orexin levels and vascular endothelial dysfunction in pregnant women with hypertensive disorder of pregnancy (HDP); A single-center prospective cohort study - EOV in HDP study

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
JPRN
Registry ID
JPRN-UMIN000056187
Enrollment
60
Registered
2024-11-30
Start date
2020-01-01
Completion date
Unknown
Last updated
2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

hypertensive disorder of Pregnancy

Interventions

Pregnant women with hypertensive disorder of pregnancy will be included. Blood sampling, vascular endothelial function test, and stress evaluation will be performed at diagnosis, before delivery, and

Sponsors

Aichi Medical University School of Medicine
Lead Sponsor

Eligibility

Sex/Gender
Female

Inclusion criteria

Inclusion criteria: Pregnant women with hypertensive disorder of pregnancy: Pregnant women with hypertensive disorder of pregnancy (HDP) Normal pregnant women: Uncomplicated pregnant women (after 36 weeks) Non-pregnant women: Non-pregnant women without complications

Exclusion criteria

Exclusion criteria: Pregnant women with hypertensive disorder of pregnancy: non-pregnant BMI less than 18 and greater than 25. Pregnant women with a chronic disease or history of a chronic disease that could affect pregnancy (diabetes, cardiac disease, respiratory disease, endocrine disease, etc.) Normal pregnant women: BMI less than 18, BMI greater than 25 Non-pregnant women: BMI less than 18, BMI greater than 25

Design outcomes

Primary

MeasureTime frame
Evaluate blood orexin levels in normal pregnant women and pregnant women with hypertensive disorder of pregnancy and in non-pregnant women. (Normal pregnant women at 34 weeks. Pregnant women with hypertensive disorder of pregnancy will be evaluated at the time of disease onset.)

Secondary

MeasureTime frame
Evaluate blood ROS levels, vascular endothelial function, and stress levels in normal pregnant women and pregnant women with hypertensive disorder of pregnancy and in non-pregnant women.(Normal pregnant women at 34 weeks. Pregnant women with hypertensive disorder of pregnancy will be evaluated at the time of disease onset.)

Countries

Japan

Contacts

Public Contacttomohito okamoto

Aichi Medical University School of Medicine Departments of Obstetrics and Gynecology

okamoto.tomohito.696@mail.aichi-med-u.ac.jp+81-561-62-3311

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026